Editorial companion

What stands out

Bloomberg hosted a neat, not-very-glamorous market moment, investors are piling into a new generation of hair loss treatments, including lotions, pills and longer-lasting injections, and some could seek approval as soon as 2027, according to Avalon Pernell. That matters because tens of millions of Americans already pay for hair restoration, so a successful, clinically proven product would meet eager pockets as well as clinical need. The headline is easy, the hard part is separating science from hype and timelines from outcomes.